CRIS Current Research Information System

ROCCHI, SERENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.562
EU - Europa 1.113
AS - Asia 664
AF - Africa 80
SA - Sud America 4
OC - Oceania 2
Totale 3.425
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.551
IT - Italia 370
SG - Singapore 213
GB - Regno Unito 200
CN - Cina 189
SE - Svezia 150
VN - Vietnam 144
DE - Germania 122
IN - India 71
IE - Irlanda 61
CI - Costa d'Avorio 30
FR - Francia 30
UA - Ucraina 30
RU - Federazione Russa 27
BG - Bulgaria 26
TG - Togo 25
ZA - Sudafrica 17
EE - Estonia 15
BE - Belgio 13
FI - Finlandia 12
CA - Canada 11
CH - Svizzera 11
ID - Indonesia 11
JO - Giordania 11
NL - Olanda 11
AT - Austria 10
ES - Italia 10
NG - Nigeria 7
PH - Filippine 7
CZ - Repubblica Ceca 4
IR - Iran 4
JP - Giappone 4
TR - Turchia 4
RO - Romania 3
AU - Australia 2
RS - Serbia 2
AR - Argentina 1
BD - Bangladesh 1
CL - Cile 1
CY - Cipro 1
EC - Ecuador 1
HU - Ungheria 1
KR - Corea 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
NO - Norvegia 1
PE - Perù 1
PL - Polonia 1
PT - Portogallo 1
SC - Seychelles 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 3.425
Salva come PNG Salva come JPEG
Città #
Chandler 220
Singapore 183
Southend 175
Fairfield 158
Ashburn 124
Bologna 120
Woodbridge 80
Ann Arbor 75
Wilmington 70
Seattle 66
Dong Ket 64
Dublin 61
Houston 60
Santa Clara 59
Cambridge 49
Boardman 46
Princeton 44
Abidjan 30
Hyderabad 30
New York 29
Sofia 26
Lomé 25
Bremen 22
Turin 22
Beijing 21
Milan 21
Fabriano 18
Redmond 17
Florence 16
Jinan 16
Westminster 16
Berlin 14
Los Angeles 14
Padova 14
San Diego 14
Brussels 12
Jacksonville 12
Amman 11
Helsinki 11
Jakarta 11
Nanjing 11
Rome 10
Vienna 10
Bern 9
Redwood City 9
Shenyang 9
Abeokuta 7
Amsterdam 7
Changsha 7
Falls Church 7
Saint Petersburg 7
Salsomaggiore Terme 7
Coimbatore 6
Guangzhou 6
Jiaxing 6
Monmouth Junction 6
Munich 6
Nanchang 6
Toronto 6
Zhengzhou 6
Dearborn 5
Paris 5
Riola 5
Shanghai 5
Anoia Superiore 4
Como 4
Frankfurt am Main 4
Mülheim 4
Parma 4
Wuhan 4
York 4
Boydton 3
Cagliari 3
Chongqing 3
Des Moines 3
Hebei 3
Imola 3
Javea 3
Kuban 3
Kunming 3
Leawood 3
Medford 3
Norwalk 3
Pianoro 3
Porto Recanati 3
Pune 3
Reggio Calabria 3
San Francisco 3
Springfield 3
Stilo 3
Taizhou 3
Tianjin 3
Tokyo 3
Verona 3
Ankara 2
Bari 2
Belgrade 2
Breda 2
Brisbane 2
Brookline 2
Totale 2.353
Salva come PNG Salva come JPEG
Nome #
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease 215
Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment 196
Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma. 185
Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma. 174
Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes 173
Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study. 147
Current and emerging triplet combination therapies for relapsed and refractory multiple myeloma 141
Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens 132
Safety and efficacy of daratumumab in dialysis-dependent renal failure secondary to multiple myeloma 132
Treatment optimization for Multiple Myeloma: schedule-dependent synergistic cytotoxicity of pomalidomide and carfilzomib in an in vitro and ex-vivo model 132
A real-world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma 132
Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis 130
Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents 122
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma 120
HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment 118
PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma 117
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma 117
Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma 110
null 98
Impact Of p53 Impaired Function On Outcomes Of Multiple Myeloma Patients Carrying Deleted TP53 and/Or Amplified MDM4 96
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients 88
Emerging and current treatment combinations for transplant-ineligible multiple myeloma patients 76
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients 71
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases 55
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials 46
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients 44
Role of serum-free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma 43
null 39
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma 37
OAB-057: Temporal-weight estimation of the copy number alterations of of 1384 Multiple Myeloma patients defines an ancestrality index impacting patients survival 30
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project 29
Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight 27
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features 25
Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study 23
OAB-006: A novel algorithm to identify, characterize and define the prognostic impact of complex catastrophic events in Multiple Myeloma 21
Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factors 21
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients 21
Novel insights and therapeutic approaches in secondary AML 19
Which is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome? 15
Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma 14
Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy 14
Abstract 2700: Negative selective pressure exerted by maintenance therapy promotes the extinction of sub-clones carrying high-risk lesions in multiple myeloma 13
Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study 12
Totale 3.570
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.906
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.906
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020473 0 0 0 0 65 59 76 84 72 47 37 33
2020/2021352 51 22 8 8 10 20 12 21 39 12 20 129
2021/2022603 63 29 28 58 41 20 17 41 26 74 101 105
2022/2023845 64 105 32 136 57 76 28 45 134 30 87 51
2023/2024396 23 41 25 35 23 90 10 74 6 22 34 13
2024/2025613 94 144 129 131 115 0 0 0 0 0 0 0
Totale 3.570